Bio-Rad Laboratories | BIO - Zinsaufwendungen Für Schuld

Aktienkurs
287.84
Täglich Wechseln
6.42 2.28%
Monatlich
5.20%
Jährlich
18.77%
Q2 Prognose
281.68




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Agilent USD 25M 2M 2025-12
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio Techne USD 2.18M 173K 2025-06
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Bruker USD 20M 4.3M 2025-09
Charles River Laboratories USD 23.78M 1.63M 2025-12
Danaher USD 63M 8M 2026-03
General Electric Aerospace USD 496M 271M 2025-12
Illumina USD 25M 0 2025-09
IQVIA Holdings USD 193M 4M 2025-12
Laboratory Of America USD 55M 1000K 2025-12
Merck USD 412M 85M 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Siemens EUR 435M 1000K 2025-12
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Tosoh JPY 884M 65M 2025-09
Waters USD 8.62M 18.02M 2025-12